Search Ontology:
ChEBI
alpha-D-Galp-(1->3)-[alpha-L-Fucp-(1->2)]-beta-D-Galp-(1->3)-beta-D-GlcpNAc
- Term ID
- CHEBI:63242
- Synonyms
-
- 6-deoxy-alpha-L-galactopyranosyl-(1->2)-[alpha-D-galactopyranosyl-(1->3)]-beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-glucopyranose
- alpha-D-Gal-(1->3)-[alpha-L-Fuc-(1->2)]-beta-D-Gal-(1->3)-beta-D-GlcNAc
- alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosamine
- alpha-L-Fuc-(1->2)-[alpha-D-Gal-(1->3)]-beta-D-Gal-(1->3)-beta-D-GlcNAc
- alpha-L-fucopyranosyl-(1->2)-[alpha-D-galactopyranosyl-(1->3)]-beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-glucopyranose
- alpha-L-fucosyl-(1->2)-[alpha-D-galactosyl-(1->3)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosamine
- alpha-L-Fucp-(1->2)-[alpha-D-Galp-(1->3)]-beta-D-Galp-(1->3)-beta-D-GlcpNAc
- alphaFuc1-2(alphaGal1-3)betaGal1-3betaGlcNAc
- alphaGal1-3(alphaFuc1-2)betaGal1-3betaGlcNAc
- beta-D-glucopyranose, O-6-deoxy-alpha-L-galactopyranosyl-(1->2)-O-[alpha-D-galactopyranosyl-(1->3)]-O-beta-D-galactopyranosyl-(1->3)-2-(acetylamino)-2-deoxy-
- blood group B type 1 tetrasaccharide
- Fucalpha1-2(Galalpha1-3)Galbeta1-3GlcNAcbeta
- Gala1-3(Fuca1-2)Galb1-3GlcNAcb
- Galalpha1,3(Fucalpha1,2)Galbeta1,3GlcNAcbeta
- Galalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta
- O-6-deoxy-alpha-L-galactopyranosyl-(1->2)-O-[alpha-D-galactopyranosyl-(1->3)]-O-beta-D-galactopyranosyl-(1->3)-2-(acetylamino)-2-deoxy-beta-D-glucopyranose
- WURCS=2.0/4,4,3/[a2122h-1b_1-5_2*NCC/3=O][a2112h-1b_1-5][a1221m-1a_1-5][a2112h-1a_1-5]/1-2-3-4/a3-b1_b2-c1_b3-d1
- Definition
- alpha-D-Galp-(1->3)-[alpha-L-Fucp-(1->2)]-beta-D-Galp-(1->3)-beta-D-GlcpNAc with beta configuration at the anomeric carbon of the GlcNAc residue at the reducing end.
- References
-
- GlyGen:G31734OS
- GlyTouCan:G31734OS
- PMID:1609521
- PMID:19443021
- PMID:24749871
- PMID:25568069
- PMID:31537530
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_role
-
- inverse is_substituent_group_from
-
Phenotype
Phenotype resulting from alpha-D-Galp-(1->3)-[alpha-L-Fucp-(1->2)]-beta-D-Galp-(1->3)-beta-D-GlcpNAc
Phenotype where environments contain alpha-D-Galp-(1->3)-[alpha-L-Fucp-(1->2)]-beta-D-Galp-(1->3)-beta-D-GlcpNAc
Phenotype modified by environments containing alpha-D-Galp-(1->3)-[alpha-L-Fucp-(1->2)]-beta-D-Galp-(1->3)-beta-D-GlcpNAc
Human Disease Model